ASX Listing Rules Appendix 3B - New Issue Announcement Application for Quotation of Additional Securities and Agreement

Appendix 3B New issue announcement

Appendix 3B

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12,

04/03/13

Name of entity

METALIKO RESOURCES LTD

ABN

120 974 567

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).


1 +Class of +securities issued or to be issued

Fully Paid Ordinary Shares (New Shares)


2 Number of +securities issued or to be issued (if known) or maximum number which may be issued

88,322,865 New Shares


3 Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid

+securities, the amount outstanding and due dates for payment; if +convertible

securities, the conversion price and dates for conversion)

Fully paid ordinary shares ranking equally with existing ordinary shares

+ See chapter 19 for defined terms.

MKO 18.09.2015 (BT) Appendix 3B Page 1

Appendix 3B

New issue announcement



4 Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted

+securities?

If the additional +securities do not rank equally, please state:
 the date from which they do
 the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
 the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Yes


5 Issue price or consideration $0.03 per New Share
6 Purpose of the issue
(If issued as consideration for the acquisition of assets, clearly identify those assets)

 for exploration and development activities at the Bronzewing and other gold projects;

 for plant maintenance and improvements at the Bronzewing Gold Project;

 to repay a loan to Dr Ruane (an executive Director of the Company) that was made to assist the Company in completing the acquisition of the Bronzewing Gold Project;

 to pay the costs of the rights issue process;

and

 to provide general working capital.



6a Is the entity an +eligible entity No that has obtained security holder approval under rule 7.1A?

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i


6b The date the security holder - resolution under rule 7.1A was passed

+ See chapter 19 for defined terms.

Appendix 3B Page 2 MKO 18.09.2015 (BT)

Appendix 3B New issue announcement



6c Number of +securities issued - without security holder approval under rule 7.1

6d Number of +securities issued - with security holder approval under rule 7.1A

6e Number of +securities issued - with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

6f Number of +securities issued under an exception in rule 7.2

88,322,865 New Shares


6g If +securities issued under rule -
7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the

+issue date and both values. Include the source of the VWAP

calculation.

6h If +securities were issued under - rule 7.1A for non-cash consideration, state date on which valuation of consideration
was released to ASX Market
Announcements

6i Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

See Annexure 1

7 +Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule

19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

19 October 2015

+ See chapter 19 for defined terms.

MKO 18.09.2015 (BT) Appendix 3B Page 3

Appendix 3B

New issue announcement


8 Number and +class of all
+securities quoted on ASX (including the +securities in section 2 if applicable)
9 Number and +class of all
+securities not quoted on ASX (including the +securities in section 2 if applicable)

10 Dividend policy (in the case of a - trust, distribution policy) on the increased capital (interests)

Part 2 - Pro rata issue


11 Is security holder approval No
required?

12 Is the issue renounceable or non- renounceable?

Non Renounceable


13 Ratio in which the +securities will be offered

1 New Share for every 4 Shares held


14 +Class of +securities to which the offer relates

Fully Paid Ordinary Shares


15 +Record date to determine entitlements

25 September 2015


16 Will holdings on different - registers (or subregisters) be aggregated for calculating entitlements?

17 Policy for deciding entitlements in relation to fractions

Fractional entitlements to New Shares will be rounded up to the nearest whole number.


18 Names of countries in which the entity has security holders who will not be sent new offer documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

United Kingdom

and any countries other than Australia, New

Zealand and Hong Kong


19 Closing date for receipt of acceptances or renunciations

5:00pm WST 12 October 2015

+ See chapter 19 for defined terms.

Appendix 3B Page 4 MKO 18.09.2015 (BT)

Appendix 3B New issue announcement



20 Names of any underwriters Kesli Chemicals Pty Ltd

21 Amount of any underwriting fee or commission

No fee is payable to the Underwriter


22 Names of any brokers to the issue -

23 Fee or commission payable to the -
broker to the issue

24 Amount of any handling fee - payable to brokers who lodge acceptances or renunciations on behalf of security holders

25 If the issue is contingent on - security holders' approval, the date of the meeting

26 Date entitlement and acceptance form and offer documents will be sent to persons entitled

30 September 2015


27 If the entity has issued options, - and the terms entitle option holders to participate on exercise,
the date on which notices will be sent to option holders

28 Date rights trading will begin (if -
applicable)

29 Date rights trading will end (if -
applicable)

30 How do security holders sell their - entitlements in full through a broker?

31 How do security holders sell part - of their entitlements through a broker and accept for the balance?

32 How do security holders dispose -
of their entitlements (except by
sale through a broker)?

33 +Issue date 19 October 2015

+ See chapter 19 for defined terms.

MKO 18.09.2015 (BT) Appendix 3B Page 5

Appendix 3B

New issue announcement

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of +securities
(tick one)
(a) +Securities described in Part 1
(b) All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid,

employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35 If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities
held by those holders
36 If the +securities are +equity securities, a distribution schedule of the additional

+securities setting out the number of holders in the categories

1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional +securities

+ See chapter 19 for defined terms.

Appendix 3B Page 6 MKO 18.09.2015 (BT)

Entities that have ticked box 34(b)

Appendix 3B New issue announcement


38 Number of +securities for which -

+quotation is sought


39 +Class of +securities for which -
quotation is sought

40 Do the +securities rank equally in - all respects from the +issue date with an existing +class of quoted

+securities?

If the additional +securities do not rank equally, please state:
 the date from which they do
 the extent to which they participate for the next dividend, (in the case of a trust,
distribution) or interest payment
 the extent to which they do not rank equally, other than in
relation to the next dividend, distribution or interest payment

41 Reason for request for quotation -
now

Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another +security, clearly identify that other +security)
42 Number and +class of all
+securities quoted on ASX (including the +securities in clause
38)

+ See chapter 19 for defined terms.

MKO 18.09.2015 (BT) Appendix 3B Page 7

Appendix 3B

New issue announcement

Quotation agreement

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX

may quote the +securities on any conditions it decides.

2 We warrant the following to ASX.

 The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 There is no reason why those +securities should not be granted

+quotation.

 An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 If we are a trust, we warrant that no person has the right to return the

+securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before

+quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Bianca Taveira

Sign here: ............................................................ Date: 18 September 2015

(Company Secretary) Print name: Bianca Taveira

== == == == ==

+ See chapter 19 for defined terms.

Appendix 3B Page 8 MKO 18.09.2015 (BT)

Appendix 3B New issue announcement

Appendix 3B - Annexure 1 Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 - Issues exceeding 15% of capital

Step 1: Calculate "A", the base figure from which the placement

capacity is calculated

Insert number of fully paid +ordinary securities on issue 12 months before the

+issue date or date of agreement to issue

307,209,994

Add the following:

• Number of fully paid +ordinary securities issued in that 12 month period under an exception in rule 7.2

• Number of fully paid +ordinary securities issued in that 12 month period with shareholder approval

• Number of partly paid +ordinary securities that became fully paid in that

12 month period

Note:

• Include only ordinary securities here - other classes of equity securities cannot be added

• Include here (if applicable) the securities the subject of the Appendix

3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

19 Mar 2015 Placement 33,333,333

10 Jul 2015 Placement 12,748,133

19 Oct 2015 Rights Issue 88,322,865

Subtract the number of fully paid

+ordinary securities cancelled during that

12 month period

Nil

"A"

441,614,325

+ See chapter 19 for defined terms.

MKO 18.09.2015 (BT) Appendix 3B Page 9

Appendix 3B

New issue announcement

Step 2: Calculate 15% of "A"

"B"

0.15

[Note: this value cannot be changed]

Multiply "A" by 0.15

66,242,148

Step 3: Calculate "C", the amount of placement capacity under rule

7.1 that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12 month period not counting those issued:

• Under an exception in rule 7.2

• Under rule 7.1A

• With security holder approval under rule 7.1 or rule 7.4

Note:

• This applies to equity securities, unless specifically excluded - not just ordinary securities

• Include here (if applicable) the securities the subject of the Appendix

3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

Nil

"C"

Nil

Step 4: Subtract "C" from ["A" x "B"] to calculate remaining

placement capacity under rule 7.1

"A" x 0.15

Note: number must be same as shown in

Step 2

66,242,148

Subtract "C"

Note: number must be same as shown in

Step 3

Nil

Total ["A" x 0.15] - "C"

66,242,148

[Note: this is the remaining placement capacity under rule 7.1]

+ See chapter 19 for defined terms.

Appendix 3B Page 10 MKO 18.09.2015 (BT)

Part 2

Appendix 3B New issue announcement

Rule 7.1A - Additional placement capacity for eligible entities

Step 1: Calculate "A", the base figure from which the placement

capacity is calculated

"A"

Note: number must be same as shown in

Step 1 of Part 1

N/A

Step 2: Calculate 10% of "A"

"D"

0.10

Note: this value cannot be changed

Multiply "A" by 0.10

N/A

Step 3: Calculate "E", the amount of placement capacity under rule

7.1A that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

• This applies to equity securities - not just ordinary securities

• Include here - if applicable - the securities the subject of the Appendix

3B to which this form is annexed

• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

• It may be useful to set out issues of securities on different dates as separate line items

"E"

N/A

+ See chapter 19 for defined terms.

MKO 18.09.2015 (BT) Appendix 3B Page 11

Appendix 3B

New issue announcement

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining

placement capacity under rule 7.1A

"A" x 0.10

Note: number must be same as shown in

Step 2

N/A

Subtract "E"

Note: number must be same as shown in

Step 3

N/A

Total ["A" x 0.10] - "E"

N/A

Note: this is the remaining placement capacity under rule 7.1A

+ See chapter 19 for defined terms.

Appendix 3B Page 12 MKO 18.09.2015 (BT)

distributed by